Won Ik Seo

5PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 03, 2025
Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients.

Chan Ho Lee, Soodong Kim, Ja Yoon Ku

|Mar 06, 2025
Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy for localized upper urinary tract urothelial carcinoma: A multicenter study.

Sung Jun Sou, Ja Yoon Ku, Kyung Hwan Kim

|Apr 08, 2024
Impact of Circulating Tumor Cell-Expressed Prostate-Specific Membrane Antigen and Prostate-Specific Antigen Transcripts in Different Stages of Prostate Cancer.

Hyungseok Cho, Seok-Soo Byun, Nak-Hoon Son

|Jan 17, 2020
Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia.

Jae Seung Chung, Won Ik Seo, Cheol Kyu Oh

|Sep 24, 2014
Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy.

Won Ik Seo, Pil Moon Kang, Dong Il Kang

Pageof 1

Frequent Collaborators

4 joint publications

Chan Ho Lee

3 joint publications

Jae Il Chung

2 joint publications

Jae-Seung Chung

2 joint publications

Hong Koo Ha